Table 1 Chief complaint that patients had before administration of the study drug
Chief complaint: symptoms before administration | Placebo (n = 50) | Ramosetron 5 μg (n = 47) |
|---|---|---|
None | 0 (0.0%) | 0 (0.0%) |
Abdominal pain/discomfort | 21 (42.0%) | 16 (34.0%) |
Stool form | 9 (18.0%) | 9 (19.1%) |
Stool frequency | 10 (20.0%) | 12 (25.5%) |
Urgency | 6 (12.0%) | 7 (14.9%) |
Feelings of incomplete evacuation | 4 (8.0%) | 3 (6.4%) |
Others | 0 (0.0%) | 0 (0.0%) |